Harrow HROW
NASDAQ HROW
$42.06 +0.42 (+1.01%)
At close: Aug 20, 2026 · 4:00 PM EDT

Harrow (HROW) Net Margin (2013 - 2026)

Harrow (HROW) posted quarterly Net Margin of 62.44% for Q1 2026, down 2527.0% year-over-year from 2.57% in Q1 2025, and down 635.08% quarter-over-quarter from 11.67% in Q4 2025.

Harrow (HROW) Net Margin (2013 - 2026) Analysis & Trends

Harrow's Net Margin history runs 14 years deep, the most recent figure standing at 62.44% for Q1 2026.

  • In Q1 2026, Net Margin fell 2527.0% year-over-year to 62.44%; the TTM figure through Mar 2026 stood at 4.16% (up 603.0% YoY), while the FY2025 annual figure was 1.89%, up 687.0% from the prior year.
  • Net Margin for Q1 2026 stood at 62.44%, down from 11.67% in the prior quarter.
  • The five-year high for Net Margin was 11.67% in Q4 2025, with the low at 62.44% in Q1 2026.
  • The 5-year median for Net Margin is 12.81% (2023), against an average of 15.68%.
  • The sharpest annual moves came in 2022 and 2023: Net Margin jumped 4193 bps in 2022, then sank 3035 bps in 2023.
  • Harrow's Net Margin stood at 5.19% in 2022, then slumped by 585 bps to 25.16% in 2023, then surged by 140 bps to 10.14% in 2024, then increased by 15 bps to 11.67% in 2025, then tumbled by 635 bps to 62.44% in 2026.
  • Business Quant data shows HROW's Net Margin at 62.44% in Q1 2026, 11.67% in Q4 2025, and 1.42% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -13.91%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.51%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Harrow 1.56 Bn 1.47 Bn 50.36 Mn -24.44%

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.44%
Mar 31, 2026 -62.44%
Dec 31, 2025 11.67%
Sep 30, 2025 1.42%
Jun 30, 2025 7.84%
Mar 31, 2025 -37.17%
Dec 31, 2024 10.14%
Sep 30, 2024 -8.57%
Jun 30, 2024 -13.23%
Mar 31, 2024 -39.22%
Dec 31, 2023 -25.16%
Sep 30, 2023 -12.81%
Jun 30, 2023 -12.64%
Mar 31, 2023 -25.45%
Dec 31, 2022 5.19%
Sep 30, 2022 -28.32%
Jun 30, 2022 -26.75%
Mar 31, 2022 -11.02%
Dec 31, 2021 -36.74%
Sep 30, 2021 -44.51%